Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress the immune system. It is not a treatment for the common cold itself, which is typically caused by viruses. However, methylprednisolone may be prescribed in certain situations where inflammation associated with a cold or its complications is a concern.
Why might a doctor prescribe methylprednisolone for cold symptoms?
Doctors may consider methylprednisolone for cold-related issues if there is significant inflammation that is not responding to other treatments. This could include severe asthma flare-ups triggered by a cold or certain allergic reactions that are exacerbated by respiratory infections [1]. It is not a first-line treatment for uncomplicated colds.
How does methylprednisolone work?
Methylprednisolone is a synthetic glucocorticoid that works by decreasing the body's inflammatory response. It inhibits the release of substances that cause inflammation, such as cytokines and prostaglandins. This can help to reduce swelling, redness, and pain [1].
What are the risks and side effects of methylprednisolone?
As with all corticosteroids, methylprednisolone carries potential risks and side effects. These can include increased susceptibility to infections, mood changes, elevated blood sugar levels, bone thinning (osteoporosis) with long-term use, and a range of other effects impacting various body systems [1]. It is crucial to use this medication only under strict medical supervision.
When does patent exclusivity for methylprednisolone expire?
Methylprednisolone is a well-established medication with a long history. Its original patents have long since expired, allowing for the production of generic versions. Information on the patent status of specific formulations or new uses of methylprednisolone can be found on resources like DrugPatentWatch.com [2].
Sources:
[1] https://www.nhs.uk/medicines/methylprednisolone/
[2] https://drugpatentwatch.com/